Ann Partridge's guest appearances

Ann Partridge

Research To Practice | Oncology Videos

WEEI/NESN Jimmy Fund Radio-Telethon

Investigating Breast Cancer

Karen Anderson

Dave Portnoy

Alex Cora

Gerry Callahan

Wyc Grousbeck

Sam Kennedy

David Ortiz

Guy Fieri

Adam Schefter

Brad Stevens

Kevin O’Connor

Shawn Thornton

Torey Krug

ERIC SMITH

David Price

OwlTail

Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer | Faculty Presentation 2: Tolerability and Other Practical Issues with OFS, Including Its Potential Utility in Preserving Fertility — Dr Ann Patridge  CME information and select publications

Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer | Faculty Presentation 2: Tolerability and Other Practical Issues with OFS, Including Its Potential Utility in Preserving Fertility — Dr Ann Patridge <a href="http://m.researchtopractice.com/InsideTheIssue2023/OvarianSuppressionBC/Presentations" rel="nofollow" target="_blank"> CME information and select publications</a>

Breast Cancer | Ann Partridge, MD, MPH

For young women, a breast cancer diagnosis presents a unique set of challenges not only due to age, but the biology of the disease as well. While a diagnosis under the age of 40 is rare, the disease tends to behave more aggressively. Compared to older breast cancer patients, young women treated for the disease tend to have an increased risk of experiencing emotional distress, treatment-induced sexual dysfunction, and concerns about future pregnancies. This is where Dr. Ann Partridge steps in. Her BCRF-supported research seeks to understand the complex issues young women with breast cancer face. Dr. Partridge studies the biology behind their breast cancers as well as focusing on how young women make their way through their experiences – whether it’s physical or emotional.   A BCRF researcher since 2016, Dr. Partridge is co-founder and director of the Young and Strong Program for Young Women with Breast Cancer, and serves as the Director of the Adult Survivorship Program at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr. Partridge is Professor of Medicine, Harvard Medical School.

For young women, a breast cancer diagnosis presents a unique set of challenges not only due to age, but the biology of the disease as well. While a diagnosis under the age of 40 is rare, the disease tends to behave more aggressively. Compared to older breast cancer patients, young women treated for the disease tend to have an increased risk of experiencing emotional distress, treatment-induced sexual dysfunction, and concerns about future pregnancies. This is where Dr. Ann Partridge steps in. Her BCRF-supported research seeks to understand the complex issues young women with breast cancer face. Dr. Partridge studies the biology behind their breast cancers as well as focusing on how young women make their way through their experiences – whether it’s physical or emotional.   A BCRF researcher since 2016, Dr. Partridge is co-founder and director of the Young and Strong Program for Young Women with Breast Cancer, and serves as the Director of the Adult Survivorship Program at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr. Partridge is Professor of Medicine, Harvard Medical School.

Young women and breast cancer, with Dr. Ann Partridge 

Kasha Waslyak

Kasha Waslyak was diagnosed with breast cancer two years ago at age 26, less than a year from her wedding. Dr. Ann Partridge, founder and director of the program for young women with breast cancer in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, discusses the advancements in breast cancer treatment and research at Dana-Farber.

Dana-Farber breast cancer patient Kasha Waslyak and Dr. Ann Partridge on Kasha’s diagnosis coming so close to her wedding and breast cancer diagnoses in younger women